SCHEMBL24719135

SCHEMBL24719135

O=C(NC1CCN(Cc2ccccc2C(F)(F)F)C1=O)c1cccc(C(F)(F)F)c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC11 Q96DB2 1/20 0.46
▸ PARP1 P09874 1/20 0.42
▸ SIGMAR1 Q99720 1/20 0.42
▸ KDM4E B2RXH2 6/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ SIRT2 Q8IXJ6 1/20 0.41
▸ SIRT1 Q96EB6 1/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ TRPC5 Q9UL62 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ FABP3 P05413 1/20 0.40
▸ FABP4 P15090 1/20 0.40
▸ RBP4 P02753 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ XIAP P98170 1/20 0.39
▸ P2RX7 Q99572 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24718259 0.85 SRC (0.43) HDAC11SIGMAR1KDM4EALDH1A1SIRT2
SCHEMBL24719128 0.85 SRC (0.43) HDAC11SIGMAR1KDM4EALDH1A1SIRT2
SCHEMBL24718654 0.84 TMPRSS4 (0.44) SIGMAR1TRPC5P2RX7
SCHEMBL1366736 0.77 HPGDS (0.44) KDM4EMEN1KMT2ASRC
SCHEMBL24719122 0.72 KMT2A (0.48) KDM4EALDH1A1SIRT2SIRT1KMT2A
SCHEMBL24718418 0.72 TP53 (0.53) HDAC11KDM4EALDH1A1SIRT2SIRT1
SCHEMBL24718637 0.71 TP53 (0.49) HDAC11SIGMAR1KDM4EALDH1A1SIRT2
SCHEMBL24718296 0.71 SRC (0.49) SIGMAR1KDM4EALDH1A1MEN1KMT2A
SCHEMBL24718308 0.71 SRC (0.49) SIGMAR1KDM4EALDH1A1MEN1KMT2A
SCHEMBL24718420 0.71 SRC (0.49) SIGMAR1KDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING UNITED STATES GOVERNMENT 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING EED, EZH2, ELP1 HDAC11 224/4885PARP1 517/4885SIGMAR1 4065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback